What is Bexotegrast used for?

Bexotegrast is being studied to treat idiopathic pulmonary fibrosis, sclerosing cholangiitis, and inflammation.

Is Bexotegrast approved for use?

No, Bexotegrast is currently a research compound in Phase 2 clinical trials.

Can Bexotegrast treat lung scarring?

It is being investigated for idiopathic pulmonary fibrosis, which is a type of lung scarring.

What is sclerosing cholangiitis?

It is a condition involving inflammation of the bile ducts that Bexotegrast is being tested to treat.

Does Bexotegrast reduce inflammation?

Research is currently looking into how Bexotegrast might help with inflammation.

Is Bexotegrast a small molecule drug?

Yes, Bexotegrast is categorized as a small molecule type drug.

Bexotegras | CAS 2376257-44-0 | CWOFQJBATWQSHL

Loading compound...

Small molecule research compound

Bexotegrast is a small molecule drug currently being studied in clinical trials. It is being researched for its potential to treat conditions like idiopathic pulmonary fibrosis, sclerosing cholangiitis, and general inflammation.

How it worksBexotegrast is a small molecule being investigated for its ability to target specific biological pathways related to inflammation and lung/bile duct conditions.

Used for

Idiopathic pulmonary fibrosisSclerosing cholangiitisInflammation

Conditions

Idiopathic pulmonary fibrosisSclerosing cholangiitisInflammation

Class

Small moleculeSmall molecule research compoundRespiratory systemHepatobiliary system

How to take

This drug is currently in the research phase (Phase 2) and is not yet approved for general use by regulatory agencies.

Talk to your doctor

Questions to ask

·What stage of clinical trials is Bexotegrast in?
·How might Bexotegrast affect my specific type of inflammation?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Talk to your doctor

Frequently asked questions (6)